UMIN-CTR Clinical Trial

Basic information
Public title	Investigation of conjunctivitis due to coronavirus
Acronym	Investigation of coronavirus conjunctivitis
Scientific Title	Investigation of conjunctivitis due to coronavirus
Scientific Title:Acronym	Investigation of coronavirus conjunctivitis
Region	Japan

Condition
Condition	Coronavirus
Classification by specialty	Ophthalmology
Classification by malignancy	Others
Genomic information	NO

Objectives
Narrative objectives1	To investigate coronavirus infection in patients with conjunctivitis
Basic objectives2	Others
Basic objectives -Others	PCR test
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes	PCR testing of coronavirus DNA
Key secondary outcomes

Base
Study type	Others,meta-analysis etc

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit	20 years-old <=
Age-upper limit	100 years-old >
Gender	Male and Female
Key inclusion criteria	Infectious conjunctivitis
Key exclusion criteria	Nothing
Target sample size	30

Research contact person
Name of lead principal investigator	1st name Tatsuya Middle name Last name Mimura
Organization	Teikyo University
Division name	School of Medicine, Department of Ophthalmology
Zip code	173-8605
Address	2-11-1 Kaga, Itabashi-ku, Tokyo, 173-8605 Japan
TEL	03-3964-1211
Email	mimurat@med.teikyo-u.ac.jp

Public contact
Name of contact person	1st name Tatsuya Middle name Last name Mimura
Organization	Teikyo University
Division name	School of Medicine, Department of Ophthalmology
Zip code	173-8605
Address	2-11-1 Kaga, Itabashi-ku, Tokyo, 173-8605 Japan
TEL	03-3964-1211
Homepage URL
Email	mimurat@med.teikyo-u.ac.jp

Sponsor
Institute	Teikyo University
Institute
Department

Funding Source
Organization	Teikyo University
Organization
Division
Category of Funding Organization	Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization	Teikyo University
Address	2-11-1 Kaga, Itabashi-ku, Tokyo, 173-8605 Japan
Tel	0339641211
Email	mimurat@med.teikyo-u.ac.jp

Secondary IDs
Secondary IDs	NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information	2020 Year 02 Month 25 Day

Related information
URL releasing protocol
Publication of results	Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status	Enrolling by invitation
Date of protocol fixation	2020 Year 02 Month 01 Day
Date of IRB	2020 Year 02 Month 01 Day
Anticipated trial start date	2020 Year 02 Month 01 Day
Last follow-up date	2021 Year 03 Month 31 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information	PCR test

Management information
Registered date	2020 Year 02 Month 25 Day
Last modified on	2020 Year 02 Month 25 Day

Link to view the page
URL(English)	https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000045152